Kyowa Hakko USA to share new research on its Cognizin citicoline ingredient at SupplySide West 2024
According to the company, the new research demonstrates the ingredient’s neuroprotective qualities and potential to enhance cognitive function, and support healthy brain aging.
Photo © iStockphoto.com/adventtr
Kyowa Hakko USA ( New York) has announced in a press release that the company will be showcasing new research at SupplySide West 2024 taking place in Las Vegas, NV between October 30-31. The research provides further validation of its recently patented citicoline ingredient called Cognizin. According to the company, the new research demonstrates the ingredient’s neuroprotective qualities and potential to enhance cognitive function, and support healthy brain aging. The research was unveiled this past summer at the American Society for Nutrition (ASN) Nutrition2024 Conference.
“We are ecstatic to bring new research supporting the efficacy of Cognizin to center stage at SupplySide West,” said Katie Emerson, Kyowa Hakko’s senior manager, scientific affairs, in a press release. “We now understand at the genetic level how citicoline delivers its benefits and could have greater implications for long-term brain health.”
Show attendees will be able to sample Cognizin in a limited edition energy drink designed exclusively at the show, called XPO NRG.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
